Inotropic options for postresuscitation myocardial dysfunction.
Gazmuri
Raúl J
RJ
Kolarova
Julieta D
JD
Ayoub
Iyad M
IM
D000818:Animals; D009202:Cardiomyopathies / Q000503:physiopathology / Q000517:prevention & control*; D016887:Cardiopulmonary Resuscitation; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004280:Dobutamine / Q000494:pharmacology / Q000627:therapeutic use*; D006323:Heart Arrest / Q000628:therapy*; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology / Q000627:therapeutic use*; D017682:Myocardial Stunning / Q000503:physiopathology / Q000517:prevention & control*; D011724:Pyridazines / Q000494:pharmacology / Q000627:therapeutic use*; D000077464:Simendan; D013552:Swine
D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan; D004280:Dobutamine